Cargando…

Membrane versus centrifuge-based therapeutic plasma exchange: a randomized prospective crossover study

BACKGROUND: Therapeutic plasma exchange (TPE) is either performed using a highly permeable filter with standard multifunctional renal replacement equipment (mTPE) or a centrifugation device (cTPE). Although both techniques are well established in clinical practice, performance of these two modes of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hafer, Carsten, Golla, Paulina, Gericke, Marion, Eden, Gabriele, Beutel, Gernot, Schmidt, Julius J., Schmidt, Bernhard M. W., De Reys, Stef, Kielstein, Jan T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360823/
https://www.ncbi.nlm.nih.gov/pubmed/26531062
http://dx.doi.org/10.1007/s11255-015-1137-3
_version_ 1782516654360494080
author Hafer, Carsten
Golla, Paulina
Gericke, Marion
Eden, Gabriele
Beutel, Gernot
Schmidt, Julius J.
Schmidt, Bernhard M. W.
De Reys, Stef
Kielstein, Jan T.
author_facet Hafer, Carsten
Golla, Paulina
Gericke, Marion
Eden, Gabriele
Beutel, Gernot
Schmidt, Julius J.
Schmidt, Bernhard M. W.
De Reys, Stef
Kielstein, Jan T.
author_sort Hafer, Carsten
collection PubMed
description BACKGROUND: Therapeutic plasma exchange (TPE) is either performed using a highly permeable filter with standard multifunctional renal replacement equipment (mTPE) or a centrifugation device (cTPE). Although both techniques are well established in clinical practice, performance of these two modes of TPE was never compared in a prospective randomized fashion. Thus we aimed to compare two commercially available therapeutic apheresis systems: mTPE (Octonova with Plasmaflo filter) and cTPE (Spectra Optia apheresis system). METHODS: Twenty-one patients (age 51.6 ± 13.5 years; 10 F/11 M; BMI 25.1 ± 5.0 kg/m(2)) were enrolled in this randomized, prospective, paired, crossover study performed in the Hannover Medical School, Germany. First treatment (either mTPE or cTPE) was chosen by an online randomization list. The primary endpoints were plasma removal efficiency with 1.2× of the total plasma volume exchanged. Secondary endpoints were total amount of plasma substances removed, such as IgG and fibrinogen. Further, the treatment effect on platelet count and complications were evaluated. RESULTS: Despite a comparable volume of the processed plasma, mTPE treatment time was 10.5 % longer than cTPE treatment time (p < 0.05), resulting in a 10 % lower plasma removal rate of the mTPE treatment. Both treatments were comparable in terms of decrease in median (IQR) IgG [pre-mTPE 5.34 (3.48–8.37), post-mTPE 1.96 (1.43–2.84) g/L; pre-cTPE 5.88 (3.42–8.84), post-cTPE 1.89 (1.21–3.52) g/L]. Also the median (IQR) amount of IgG removed in mTPE [13.14 (7.42–16.10) g] was not different from the cTPE treatment [9.30 (6.26–15.69) g]. This was also true for IgM removal. Platelet loss during mTPE was nearly twice as much as with cTPE (15 ± 9 versus 7 ± 9 %, p < 0.05). CONCLUSION: Although the centrifugal procedures were conducted using flow rates that could easily be obtained using peripheral access, plasma removal efficiency was significantly higher and treatment time was significantly lower in cTPE as compared to mTPE. Despite this lower treatment time, the decline in markers of procedure efficacy was comparable. Especially in centers performing many procedures per year, cTPE in contrast to mTPE can reduce treatment time without compromising treatment efficacy.
format Online
Article
Text
id pubmed-5360823
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-53608232017-04-04 Membrane versus centrifuge-based therapeutic plasma exchange: a randomized prospective crossover study Hafer, Carsten Golla, Paulina Gericke, Marion Eden, Gabriele Beutel, Gernot Schmidt, Julius J. Schmidt, Bernhard M. W. De Reys, Stef Kielstein, Jan T. Int Urol Nephrol Nephrology - Original Paper BACKGROUND: Therapeutic plasma exchange (TPE) is either performed using a highly permeable filter with standard multifunctional renal replacement equipment (mTPE) or a centrifugation device (cTPE). Although both techniques are well established in clinical practice, performance of these two modes of TPE was never compared in a prospective randomized fashion. Thus we aimed to compare two commercially available therapeutic apheresis systems: mTPE (Octonova with Plasmaflo filter) and cTPE (Spectra Optia apheresis system). METHODS: Twenty-one patients (age 51.6 ± 13.5 years; 10 F/11 M; BMI 25.1 ± 5.0 kg/m(2)) were enrolled in this randomized, prospective, paired, crossover study performed in the Hannover Medical School, Germany. First treatment (either mTPE or cTPE) was chosen by an online randomization list. The primary endpoints were plasma removal efficiency with 1.2× of the total plasma volume exchanged. Secondary endpoints were total amount of plasma substances removed, such as IgG and fibrinogen. Further, the treatment effect on platelet count and complications were evaluated. RESULTS: Despite a comparable volume of the processed plasma, mTPE treatment time was 10.5 % longer than cTPE treatment time (p < 0.05), resulting in a 10 % lower plasma removal rate of the mTPE treatment. Both treatments were comparable in terms of decrease in median (IQR) IgG [pre-mTPE 5.34 (3.48–8.37), post-mTPE 1.96 (1.43–2.84) g/L; pre-cTPE 5.88 (3.42–8.84), post-cTPE 1.89 (1.21–3.52) g/L]. Also the median (IQR) amount of IgG removed in mTPE [13.14 (7.42–16.10) g] was not different from the cTPE treatment [9.30 (6.26–15.69) g]. This was also true for IgM removal. Platelet loss during mTPE was nearly twice as much as with cTPE (15 ± 9 versus 7 ± 9 %, p < 0.05). CONCLUSION: Although the centrifugal procedures were conducted using flow rates that could easily be obtained using peripheral access, plasma removal efficiency was significantly higher and treatment time was significantly lower in cTPE as compared to mTPE. Despite this lower treatment time, the decline in markers of procedure efficacy was comparable. Especially in centers performing many procedures per year, cTPE in contrast to mTPE can reduce treatment time without compromising treatment efficacy. Springer Netherlands 2015-11-03 2016 /pmc/articles/PMC5360823/ /pubmed/26531062 http://dx.doi.org/10.1007/s11255-015-1137-3 Text en © Springer Science+Business Media Dordrecht 2015
spellingShingle Nephrology - Original Paper
Hafer, Carsten
Golla, Paulina
Gericke, Marion
Eden, Gabriele
Beutel, Gernot
Schmidt, Julius J.
Schmidt, Bernhard M. W.
De Reys, Stef
Kielstein, Jan T.
Membrane versus centrifuge-based therapeutic plasma exchange: a randomized prospective crossover study
title Membrane versus centrifuge-based therapeutic plasma exchange: a randomized prospective crossover study
title_full Membrane versus centrifuge-based therapeutic plasma exchange: a randomized prospective crossover study
title_fullStr Membrane versus centrifuge-based therapeutic plasma exchange: a randomized prospective crossover study
title_full_unstemmed Membrane versus centrifuge-based therapeutic plasma exchange: a randomized prospective crossover study
title_short Membrane versus centrifuge-based therapeutic plasma exchange: a randomized prospective crossover study
title_sort membrane versus centrifuge-based therapeutic plasma exchange: a randomized prospective crossover study
topic Nephrology - Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360823/
https://www.ncbi.nlm.nih.gov/pubmed/26531062
http://dx.doi.org/10.1007/s11255-015-1137-3
work_keys_str_mv AT hafercarsten membraneversuscentrifugebasedtherapeuticplasmaexchangearandomizedprospectivecrossoverstudy
AT gollapaulina membraneversuscentrifugebasedtherapeuticplasmaexchangearandomizedprospectivecrossoverstudy
AT gerickemarion membraneversuscentrifugebasedtherapeuticplasmaexchangearandomizedprospectivecrossoverstudy
AT edengabriele membraneversuscentrifugebasedtherapeuticplasmaexchangearandomizedprospectivecrossoverstudy
AT beutelgernot membraneversuscentrifugebasedtherapeuticplasmaexchangearandomizedprospectivecrossoverstudy
AT schmidtjuliusj membraneversuscentrifugebasedtherapeuticplasmaexchangearandomizedprospectivecrossoverstudy
AT schmidtbernhardmw membraneversuscentrifugebasedtherapeuticplasmaexchangearandomizedprospectivecrossoverstudy
AT dereysstef membraneversuscentrifugebasedtherapeuticplasmaexchangearandomizedprospectivecrossoverstudy
AT kielsteinjant membraneversuscentrifugebasedtherapeuticplasmaexchangearandomizedprospectivecrossoverstudy